A Bibliometric Analysis of Urologic Chronic Pelvic Pain Syndrome From 2000 to 2022

References

• Campbell J. The fifth vital sign revisited. Pain. 2016;157(1):3–4. doi:10.1097/j.pain.0000000000000413
   PubMedGoogle Scholar
• Clemens JQ, Mullins C, Kusek JW, et al. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol. 2014;14:14. doi:10.1186/1471-2490-14-14
   PubMedGoogle Scholar
• Dagher A, Curatolo A, Sachdev M, et al. Identification of novel non-invasive biomarkers of urinary chronic pelvic pain syndrome: findings from the multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network. BJU Int. 2017;120(1):130–142. doi:10.1111/bju.13832
   PubMedGoogle Scholar
• Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND interstitial cystitis epidemiology male study. J Urol. 2013;189(1):141–145. doi:10.1016/j.juro.2012.08.088
   PubMed Web of Science ®Google Scholar
• Daniels NA, Link CL, Barry MJ, McKinlay JB. Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome. J Natl Med Assoc. 2007;99(5):509–516.
   PubMedGoogle Scholar
• Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–544. doi:10.1016/j.juro.2011.03.132
   PubMed Web of Science ®Google Scholar
• Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. Bmc Public Health. 2006;6:6. doi:10.1186/1471-2458-6-6
   PubMedGoogle Scholar
• Smith DR. Bibliometrics, dermatology and contact dermatitis. Contact Dermatitis. 2008;59(3):133–136. doi:10.1111/j.1600-0536.2008.01405.x
   PubMed Web of Science ®Google Scholar
• Chen CM, CiteSpace II. Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Tec. 2006;57(3):359–377. doi:10.1002/asi.20317
   Web of Science ®Google Scholar
• Pan XL, Yan EJ, Cui M, Hua WN. Examining the usage, citation, and diffusion patterns of bibliometric mapping software: a comparative study of three tools. J Informetr. 2018;12(2):481–493. doi:10.1016/j.joi.2018.03.005
   Web of Science ®Google Scholar
• van Eck NJ, Waltman L. Software survey: vOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/s11192-009-0146-3
   PubMed Web of Science ®Google Scholar
• Chen C, Chen Y, Hou J, Liang Y. CiteSpace I: detecting and visualizing emerging trends and transient patterns in scientific literature. J China Soc Sci Tech Inf. 2009;28(3):401–421.
   Google Scholar
• Hirsch J. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci U S A. 2005;102(46):16569–16572.
   PubMed Web of Science ®Google Scholar
• Egghe L. Theory and practise of the g-index. Scientometrics. 2006;69(1):131–152. doi:10.1007/s11192-006-0144-7
   Web of Science ®Google Scholar
• Bradford SC. Sources of information on specific subjects 1934. J Inf Sci. 1985;10(4):176–180. doi:10.1177/016555158501000407
   Web of Science ®Google Scholar
• Litwin MS, McNaughton-Collins M, Fowler FJ, et al. The national institutes of health chronic prostatitis symptom index: development and validation of a new outcome measure. J Urol. 1999;162(2):369–375. doi:10.1016/S0022-5347(05)68562-X
   PubMed Web of Science ®Google Scholar
• Collins MM, Stafford RS, O’Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol. 1998;159(4):1224–1228. doi:10.1016/S0022-5347(01)63564-X
   PubMed Web of Science ®Google Scholar
• Landis JR, Williams DA, Lucia MS, et al. The MAPP research network: design, patient characterization and operations. BMC Urol. 2014;14. doi:10.1186/1471-2490-14-58
   Google Scholar
• Magistro G, Wagenlehner FME, Grabe M, Weidner W, Stief CG, Nickel JC. Contemporary management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol. 2016;69(2):286–297. doi:10.1016/j.eururo.2015.08.061
   PubMed Web of Science ®Google Scholar
• Chen CM, Leydesdorff L. Patterns of connections and movements in dual-map overlays: a new method of publication portfolio analysis. J Assoc Inf Sci Technol. 2014;65(2):334–351. doi:10.1002/asi.22968
   Web of Science ®Google Scholar
• Chen CM, Dubin R, Kim MC. Emerging trends and new developments in regenerative medicine: a scientometric update (2000–2014). Expert Opin Biol Ther. 2014;14(9):1295–1317. doi:10.1517/14712598.2014.920813
   PubMed Web of Science ®Google Scholar
• Malde S, Palmisani S, Al-Kaisy A, Sahai A. Guideline of guidelines: bladder pain syndrome. BJU Int. 2018;122(5):729–743. doi:10.1111/bju.14399
   PubMed Web of Science ®Google Scholar
• Rosen JM, Klumpp DJ. Mechanisms of pain from urinary tract infection. Int J Urol. 2014;21:26–32. doi:10.1111/iju.12309
   PubMedGoogle Scholar
• Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology. 1997;49(5A):14–40. doi:10.1016/S0090-4295(99)80329-X
   PubMedGoogle Scholar
• Reche A, Buffington CAT. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol. 1998;159(3):1045–1048. doi:10.1016/S0022-5347(01)63833-3
   PubMedGoogle Scholar
• Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology. 2007;69:9–16. doi:10.1016/j.urology.2006.03.084
   PubMed Web of Science ®Google Scholar
• Wada N, Ameda K, Furuno T, Okada H, Date I, Kakizaki H. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis. J Urol. 2015;193(6):1987–1993. doi:10.1016/j.juro.2015.01.010
   PubMedGoogle Scholar
• Liu BL, Yang F, Zhan HL, et al. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Urol Int. 2014;92(2):202–208. doi:10.1159/000355175
   PubMedGoogle Scholar
• Peeker R, Enerback L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000;163(3):1009–1015. doi:10.1016/S0022-5347(05)67873-1
   PubMed Web of Science ®Google Scholar
• Hofmeister MA, He F, Ratliff TL, Mahoney T, Becich MJ. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology. 1997;49(5A):41–47. doi:10.1016/S0090-4295(99)80330-6
   PubMedGoogle Scholar
• Munoz A, Smith CP, Boone TB, Somogyi GT. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int. 2011;58(3):295–300. doi:10.1016/j.neuint.2010.12.002
   PubMedGoogle Scholar
• Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70(1):16–18. doi:10.1016/j.urology.2007.02.067
   PubMed Web of Science ®Google Scholar
• Nickel JC, Payne CK, Forrest J, Parsons CL, Wan GJ, Xiao XY. The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. J Urol. 2009;181(6):2555–2561. doi:10.1016/j.juro.2009.02.030
   PubMed Web of Science ®Google Scholar
• Bade J, Ishizuka O, Yoshida M. Workshop 8: future research needs for the definition/diagnosis of interstitial cystitis. Int J Urol. 2003;10:S31–S34. doi:10.1046/j.1442-2042.10.s1.9.x
   PubMed Web of Science ®Google Scholar
• Buffington CAT. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol. 2004;172(4):1242–1248. doi:10.1097/01.ju.0000137953.49304.6c
   PubMedGoogle Scholar
• Soler R, Bruschini H, Freire MP, Alves MT, Srougi M, Ortiz V. Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury. J Urol. 2008;180(4):1527–1531. doi:10.1016/j.juro.2008.06.006
   PubMedGoogle Scholar
• Rosamilia A, Cann L, Scurry J, Rogers P, Dwyer P. Bladder microvasculature and the effects of hydrodistention in interstitial cystitis. Urology. 2001;57(6 Suppl 1):132. doi:10.1016/S0090-4295(01)01149-9
   PubMedGoogle Scholar
• Dell JR, Parsons CL. Multimodal therapy for interstitial cystitis. J Reprod Med. 2004;49(3):243–252.
   PubMedGoogle Scholar
• Sonmez MG, Kozanhan B. Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome. Ginekol Pol. 2017;88(2):61–67. doi:10.5603/GP.a2017.0013
   PubMedGoogle Scholar
• Padilla-Fernandez B, Hernandez-Hernandez D, Castro-Diaz DM. Current role of neuromodulation in bladder pain syndrome/interstitial cystitis. Ther Adv Urol. 2022;14:17562872221135941. doi:10.1177/17562872221135941
   Google Scholar
• Barr S. Diagnosis and management of interstitial cystitis. Obstet Gynecol Clin North Am. 2014;41(3):397–407. doi:10.1016/j.ogc.2014.04.001
   PubMedGoogle Scholar
• Kim E, Brown L, Seltzer E, et al. Development of a patient-centered text message-based platform for the self-management of interstitial cystitis/bladder pain syndrome symptoms. Neurourol Urodyn. 2023;42(2):510–522. doi:10.1002/nau.25115
   PubMedGoogle Scholar
• Schaeffer E. Re: atypical microorganisms in expressed prostatic secretion from patients with chronic prostatitis/chronic pelvic pain syndrome: microbiological results from a case-control study. J Urol. 2015;193(3):863.
   Google Scholar
• Koh J, Ko H, Wang S, et al. Depression and somatic symptoms may influence on chronic prostatitis/chronic pelvic pain syndrome: a preliminary study. Psychiatry Investig. 2014;11(4):495–498. doi:10.4306/pi.2014.11.4.495
   PubMedGoogle Scholar
• Clemens J, Brown S, Calhoun E. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol. 2008;180(4):1378–1382. doi:10.1016/j.juro.2008.06.032
   PubMedGoogle Scholar
• Shoskes D, Berger R, Elmi A, Landis J, Propert K, Zeitlin S. Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol. 2008;179(2):556–560. doi:10.1016/j.juro.2007.09.088
   PubMedGoogle Scholar
• Yilmaz U, Liu Y, Berger R, Yang C. Autonomic nervous system changes in men with chronic pelvic pain syndrome. J Urol. 2007;177(6):2170–2174. doi:10.1016/j.juro.2007.01.144
   PubMedGoogle Scholar
• Shahed AR, Shoskes DA. Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J Urol. 2001;166(5):1738–1741. doi:10.1016/S0022-5347(05)65664-9
   PubMed Web of Science ®Google Scholar
• Pontari M, Ruggieri M. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172(3):839–845. doi:10.1097/01.ju.0000136002.76898.04
   PubMed Web of Science ®Google Scholar
• Berger RE. Effect of antibiotic therapy on interleukin-6 in fresh semen and postmasturbation urine samples of patients with chronic prostatitis/chronic pelvic pain syndrome. Urology. 2009;73(6):1428–1429. doi:10.1016/j.urology.2008.05.059
   PubMedGoogle Scholar
• He L, Wang Y, Long Z, Jiang C. Clinical significance of IL-2, IL-10, and TNF-alpha in prostatic secretion of patients with chronic prostatitis. Urology. 2010;75(3):654–657. doi:10.1016/j.urology.2009.09.061
   PubMedGoogle Scholar
• Desireddi NV, Campbell PL, Stern JA, et al. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1 alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol. 2008;179(5):1857–1861. doi:10.1016/j.juro.2008.01.028
   PubMedGoogle Scholar
• Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol. 2012;303(6):R580–R589. doi:10.1152/ajpregu.00240.2012
   Google Scholar
• Berger RE. A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study comment. J Urol. 2010;183(4):1403. doi:10.1016/j.juro.2009.12.072
   Google Scholar
• Haenen G, Paquay J, Korthouwer R, Bast A. Peroxynitrite scavenging by flavonoids. Biochem Biophys Res Commun. 1997;236(3):591–593. doi:10.1006/bbrc.1997.7016
   PubMed Web of Science ®Google Scholar
• Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res. 1993;13(6A):2165–2170.
   PubMed Web of Science ®Google Scholar
• Zhang K, Liu YX, Yang WB, et al. Efficacy and safety of ningmitai capsule in patients with chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized, double-blind, placebo-controlled trial. Urology. 2021;153:264–269. doi:10.1016/j.urology.2021.01.018
   PubMedGoogle Scholar
• Panunzio A, Tafuri A, Mazzucato G, et al. Botulinum Toxin-A injection in chronic pelvic pain syndrome treatment: a systematic review and pooled meta-analysis. Toxins. 2022;14:1. doi:10.3390/toxins14010025
   Google Scholar
• Wheeler A, Smith HS. Botulinum toxins: mechanisms of action, antinociception and clinical applications. Toxicology. 2013;306:124–146. doi:10.1016/j.tox.2013.02.006
   PubMed Web of Science ®Google Scholar
• White B, Welge M, Auvil L, et al. Microbiota of chronic prostatitis/chronic pelvic pain syndrome are distinct from interstitial cystitis/bladder pain syndrome. medRxiv. 2021;2021:3.
   Google Scholar
• Ullrich PM, Turner JA, Ciol M, Berger R. Stress is associated with subsequent pain and disability among men with nonbacterial prostatitis/pelvic pain. Ann Behav Med. 2005;30(2):112–118. doi:10.1207/s15324796abm3002_3
   PubMedGoogle Scholar
• Pontari MA. Chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: are they related? Curr Urol Rep. 2006;7(4):329–334. doi:10.1007/s11934-996-0013-1
   PubMedGoogle Scholar